English

CADENCE PHARMACEUTICALS INC

EDGAR

CADX Annual report (10-K) · filed 2014-02-28

34 filing records in this dataset, filed from 2006-11-30 to 2014-02-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

35.3 million USD

2013 Q4 · USD

Exact inputs and evidence

Revenue: 35313000 USD Source

Operating margin

-8.49%

2013 Q4 · %

Exact inputs and evidence

Operating Income: -27544000 USD Source
Operating Income: -24547000 USD Source
Revenue: 35313000 USD Source

Operating cash flow

647 thousand USD

2013 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -23193000 USD Source
Operating Cash Flow: -23840000 USD Source

Free cash flow

222 thousand USD

2013 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -23193000 USD Source
Operating Cash Flow: -23840000 USD Source
Capital Expenditure: 505000 USD Source
Capital Expenditure: 80000 USD Source

Cash and cash equivalents: 55.1 million USD 2013-12-31 Source
Exact value

55075000 USD
Long-term debt including current maturities: 29.3 million USD 2013-12-31 Source
Exact value

29315000 USD
Shares outstanding: 86.7 million shares 2013-12-31 Source
Exact value

86719716 shares

Reported share-count change

1.23% · 1.05 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

85668668 shares · 2012-12-31· Source
86719716 shares · 2013-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

113 million USD

2013-01-01 – 2013-12-31

Exact inputs and evidence

Revenue: 23612000 USD · 2013-01-01 – 2013-03-31 Source
Revenue: 24674000 USD · 2013-04-01 – 2013-06-30 Source
Revenue: 28957000 USD · 2013-07-01 – 2013-09-30 Source
Revenue: 35313000 USD · 2013-10-01 – 2013-12-31 Source

Net income

-24.3 million USD

2013-01-01 – 2013-12-31

Exact inputs and evidence

Net income: -1363000 USD · 2013-01-01 – 2013-03-31 Source
Net income: -11875000 USD · 2013-04-01 – 2013-06-30 Source
Net income: -6938000 USD · 2013-07-01 – 2013-09-30 Source
Net income: -4118000 USD · 2013-10-01 – 2013-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-02-28.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2013-12-31
Operating income: 8 of 11 periods available· newest 2013-12-31
Net income: 8 of 11 periods available· newest 2013-12-31
Operating cash flow: 8 of 11 periods available· newest 2013-12-31
Capital expenditure: 8 of 11 periods available· newest 2013-12-31
Total assets: 3 of 11 periods available· newest 2013-12-31
Total liabilities: 3 of 11 periods available· newest 2013-12-31
Current assets: 3 of 11 periods available· newest 2013-12-31
Current liabilities: 3 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2013-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2013-12-31
Shares outstanding: 3 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+124.3%

Prior period

USD 50.18 million

2012-01-01 – 2012-12-31
Current period

USD 112.56 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

112556000 − 50184000 = 62372000 USD

50184000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
112556000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Year-over-year change in Revenue: 62372000 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 112556000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1085665 Filing: 000119312514077365 Input fundies:Revenue: 50184000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1140683 Filing: 000119312514077365
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 56.68 million

Prior period

−USD 80.97 million

2012-01-01 – 2012-12-31
Current period

−USD 24.29 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-24294000 − -80973000 = 56679000 USD

-80973000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-24294000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Year-over-year change in Net income: 56679000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -24294000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1088085 Filing: 000119312514077365 Input fundies:NetIncome: -80973000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1142752 Filing: 000119312514077365
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 41.11 million

Prior period

−USD 64.3 million

2012-01-01 – 2012-12-31
Current period

−USD 23.19 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-23193000 − -64299000 = 41106000 USD

-64299000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-23193000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Year-over-year change in Operating cash flow: 41106000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -23193000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#567716 Filing: 000119312514077365 Input fundies:OperatingCashFlow: -64299000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1134303 Filing: 000119312514077365
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-70.4%

Prior period

USD 1.71 million

2012-01-01 – 2012-12-31
Current period

USD 505,000

2013-01-01 – 2013-12-31

Exact inputs and evidence

505000 − 1705000 = -1200000 USD

1705000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
505000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Year-over-year change in Capital expenditure: -1200000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 505000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1082035 Filing: 000119312514077365 Input fundies:CapitalExpenditure: 1705000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1136336 Filing: 000119312514077365
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 112.56 million 100% of revenue
Cost of revenue USD 37.97 million 34% of revenue
Operating expenses USD 101.23 million 90% of revenue
Other operating costs Derived USD 902,000 0.8% of revenue
Operating income −USD 27.54 million −24% of revenue
Tax, interest and other Derived −USD 3.25 million −2.9% of revenue
Net income −USD 24.29 million −22% of revenue

Cash

Operating cash flow −USD 23.19 million −21% of revenue
Capital expenditure USD 505,000 0.4% of revenue
Free cash flow Derived −USD 23.7 million −21% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 Operating loss: operating costs were 632% of revenue.
2012 Operating loss: operating costs were 253% of revenue.
2013 Operating loss: operating costs were 124% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2011-01-01 – 2011-12-31	16696000	105438000 Derived	-88742000	4279000 Derived	-93021000	-80885000 Derived	Source 2011-01-01 – 2011-12-31: 16696000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -88742000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -93021000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -78152000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 2733000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	50184000	126858000 Derived	-76674000	4299000 Derived	-80973000	-66004000 Derived	Source 2012-01-01 – 2012-12-31: 50184000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -76674000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -80973000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -64299000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 1705000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	112556000	140100000 Derived	-27544000	-3250000 Derived	-24294000	-23698000 Derived	Source 2013-01-01 – 2013-12-31: 112556000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -27544000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -24294000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -23193000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 505000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 112.6M 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Revenue	16696000	Revenue: 16696000 Open source
20122012-12-31	Revenue	50184000	Revenue: 50184000 Open source
20132013-12-31	Revenue	112556000	Revenue: 112556000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

124.3% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Year over year	No prior comparable period	Revenue: 16696000 Open source
20122012-12-31	Year over year	200.6%	Revenue: 50184000 Open source Revenue: 16696000 Open source
20132013-12-31	Year over year	124.3%	Revenue: 112556000 Open source Revenue: 50184000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -24.5% 2013

Net margin -21.6% 2013

Free cash flow margin -21.1% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Operating margin	-531.5%	Operating Income: -88742000 Open source Revenue: 16696000 Open source
20122012-12-31	Operating margin	-152.8%	Operating Income: -76674000 Open source Revenue: 50184000 Open source
20132013-12-31	Operating margin	-24.5%	Operating Income: -27544000 Open source Revenue: 112556000 Open source
20112011-12-31	Net margin	-557.1%	Net Income: -93021000 Open source Revenue: 16696000 Open source
20122012-12-31	Net margin	-161.4%	Net Income: -80973000 Open source Revenue: 50184000 Open source
20132013-12-31	Net margin	-21.6%	Net Income: -24294000 Open source Revenue: 112556000 Open source
20112011-12-31	Free cash flow margin	-484.5%	Revenue: 16696000 Open source Operating Cash Flow: -78152000 Open source Capital Expenditure: 2733000 Open source
20122012-12-31	Free cash flow margin	-131.5%	Revenue: 50184000 Open source Operating Cash Flow: -64299000 Open source Capital Expenditure: 1705000 Open source
20132013-12-31	Free cash flow margin	-21.1%	Revenue: 112556000 Open source Operating Cash Flow: -23193000 Open source Capital Expenditure: 505000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -23.2M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Operating cash flow	-78152000	Operating Cash Flow: -78152000 Open source
20122012-12-31	Operating cash flow	-64299000	Operating Cash Flow: -64299000 Open source
20132013-12-31	Operating cash flow	-23193000	Operating Cash Flow: -23193000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -23.7M 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Free cash flow	-80885000	Operating Cash Flow: -78152000 Open source Capital Expenditure: 2733000 Open source
20122012-12-31	Free cash flow	-66004000	Operating Cash Flow: -64299000 Open source Capital Expenditure: 1705000 Open source
20132013-12-31	Free cash flow	-23698000	Operating Cash Flow: -23193000 Open source Capital Expenditure: 505000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

61.6% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Liabilities / assets	27.1%	Total Liabilities: 44355000 Open source Total Assets: 163665000 Open source
20122012-12-31	Liabilities / assets	51.1%	Total Liabilities: 49868000 Open source Total Assets: 97679000 Open source
20132013-12-31	Liabilities / assets	61.6%	Total Liabilities: 55925000 Open source Total Assets: 90803000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.13× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Current assets / current liabilities	8.52×	Current Assets: 132434000 Open source Current Liabilities: 15542000 Open source
20122012-12-31	Current assets / current liabilities	3.64×	Current Assets: 76516000 Open source Current Liabilities: 20999000 Open source
20132013-12-31	Current assets / current liabilities	2.13×	Current Assets: 77888000 Open source Current Liabilities: 36543000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 7.71 million Exact value Exact value: -7705612 USD 2005-01-01 – 2005-12-31: -7705612 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2005-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -7705612 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7705612 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0000936392-08-000195.txt#24142 The citation records this snapshot. The page link may show a newer release later.	−USD 6.92 million Exact value Exact value: -6924369 USD 2005-01-01 – 2005-12-31: -6924369 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2005-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -6924369 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6924369 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0000936392-08-000195.txt#24801 The citation records this snapshot. The page link may show a newer release later.	USD 45,881 Exact value Exact value: 45881 USD 2005-01-01 – 2005-12-31: 45881 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2005-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 45881 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 45881 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0000936392-08-000195.txt#25133 The citation records this snapshot. The page link may show a newer release later.	−USD 6.97 million Calculation and evidence -6924369 − 45881 USD Exact free cash flow: -6970250 USD 2005-01-01 – 2005-12-31: -6924369 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 45881 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2005-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -6970250 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6924369 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0000936392-08-000195.txt#24801 Input fundies:CapitalExpenditure: 45881 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0000936392-08-000195.txt#25133 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 52.17 million Exact value Exact value: -52172941 USD 2006-01-01 – 2006-12-31: -52172941 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2006-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -52172941 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52172941 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-09-055269.txt#7359 The citation records this snapshot. The page link may show a newer release later.	−USD 41.71 million Exact value Exact value: -41712262 USD 2006-01-01 – 2006-12-31: -41712262 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2006-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -41712262 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41712262 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-09-055269.txt#7612 The citation records this snapshot. The page link may show a newer release later.	USD 2.51 million Exact value Exact value: 2509063 USD 2006-01-01 – 2006-12-31: 2509063 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2006-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 2509063 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2509063 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-09-055269.txt#7720 The citation records this snapshot. The page link may show a newer release later.	−USD 44.22 million Calculation and evidence -41712262 − 2509063 USD Exact free cash flow: -44221325 USD 2006-01-01 – 2006-12-31: -41712262 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 2509063 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2006-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -44221325 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41712262 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-09-055269.txt#7612 Input fundies:CapitalExpenditure: 2509063 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-09-055269.txt#7720 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 51.71 million Exact value Exact value: -51713554 USD 2007-01-01 – 2007-12-31: -51713554 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2007-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -51713554 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51713554 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-10-057258.txt#7531 The citation records this snapshot. The page link may show a newer release later.	−USD 40.67 million Exact value Exact value: -40674670 USD 2007-01-01 – 2007-12-31: -40674670 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2007-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -40674670 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40674670 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-10-057258.txt#7819 The citation records this snapshot. The page link may show a newer release later.	USD 2.1 million Exact value Exact value: 2096683 USD 2007-01-01 – 2007-12-31: 2096683 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2007-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 2096683 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2096683 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-10-057258.txt#7927 The citation records this snapshot. The page link may show a newer release later.	−USD 42.77 million Calculation and evidence -40674670 − 2096683 USD Exact free cash flow: -42771353 USD 2007-01-01 – 2007-12-31: -40674670 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2096683 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2007-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -42771353 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40674670 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-10-057258.txt#7819 Input fundies:CapitalExpenditure: 2096683 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-10-057258.txt#7927 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 57.1 million Exact value Exact value: -57099000 USD 2008-01-01 – 2008-12-31: -57099000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2008-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -57099000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57099000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-11-056422.txt#8356 The citation records this snapshot. The page link may show a newer release later.	−USD 49.69 million Exact value Exact value: -49688000 USD 2008-01-01 – 2008-12-31: -49688000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2008-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -49688000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -49688000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-11-056422.txt#8680 The citation records this snapshot. The page link may show a newer release later.	USD 1.74 million Exact value Exact value: 1743000 USD 2008-01-01 – 2008-12-31: 1743000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2008-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 1743000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1743000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-11-056422.txt#8806 The citation records this snapshot. The page link may show a newer release later.	−USD 51.43 million Calculation and evidence -49688000 − 1743000 USD Exact free cash flow: -51431000 USD 2008-01-01 – 2008-12-31: -49688000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1743000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2008-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -51431000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -49688000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-11-056422.txt#8680 Input fundies:CapitalExpenditure: 1743000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/0001193125-11-056422.txt#8806 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 56.64 million Exact value Exact value: -56643000 USD 2010-01-01 – 2010-12-31: -56643000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2010-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -56643000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56643000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312513098806/cadx-20121231.xml#114052 Filing: 000119312513098806 The citation records this snapshot. The page link may show a newer release later.	−USD 58.86 million Exact value Exact value: -58860000 USD 2010-01-01 – 2010-12-31: -58860000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2010-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -58860000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58860000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312513098806/cadx-20121231.xml#103683 Filing: 000119312513098806 The citation records this snapshot. The page link may show a newer release later.	USD 3.75 million Exact value Exact value: 3754000 USD 2010-01-01 – 2010-12-31: 3754000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2010-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 3754000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3754000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312513098806/cadx-20121231.xml#104998 Filing: 000119312513098806 The citation records this snapshot. The page link may show a newer release later.	−USD 62.61 million Calculation and evidence -58860000 − 3754000 USD Exact free cash flow: -62614000 USD 2010-01-01 – 2010-12-31: -58860000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 3754000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2010-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -62614000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58860000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312513098806/cadx-20121231.xml#103683 Filing: 000119312513098806 Input fundies:CapitalExpenditure: 3754000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312513098806/cadx-20121231.xml#104998 Filing: 000119312513098806 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 93.02 million Exact value Exact value: -93021000 USD 2011-01-01 – 2011-12-31: -93021000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2011-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -93021000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -93021000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#119265 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	−USD 78.15 million Exact value Exact value: -78152000 USD 2011-01-01 – 2011-12-31: -78152000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2011-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -78152000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -78152000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#110002 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	USD 2.73 million Exact value Exact value: 2733000 USD 2011-01-01 – 2011-12-31: 2733000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2011-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 2733000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2733000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#112295 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	−USD 80.89 million Calculation and evidence -78152000 − 2733000 USD Exact free cash flow: -80885000 USD 2011-01-01 – 2011-12-31: -78152000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 2733000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2011-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -80885000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -78152000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#110002 Filing: 000119312514077365 Input fundies:CapitalExpenditure: 2733000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#112295 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 80.97 million Exact value Exact value: -80973000 USD 2012-01-01 – 2012-12-31: -80973000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2012-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -80973000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -80973000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1142752 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	−USD 64.3 million Exact value Exact value: -64299000 USD 2012-01-01 – 2012-12-31: -64299000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2012-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -64299000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64299000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1134303 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	USD 1.71 million Exact value Exact value: 1705000 USD 2012-01-01 – 2012-12-31: 1705000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2012-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 1705000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1705000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1136336 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	−USD 66 million Calculation and evidence -64299000 − 1705000 USD Exact free cash flow: -66004000 USD 2012-01-01 – 2012-12-31: -64299000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 1705000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2012-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -66004000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64299000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1134303 Filing: 000119312514077365 Input fundies:CapitalExpenditure: 1705000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1136336 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 24.29 million Exact value Exact value: -24294000 USD 2013-01-01 – 2013-12-31: -24294000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Net Income: -24294000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24294000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1088085 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	−USD 23.19 million Exact value Exact value: -23193000 USD 2013-01-01 – 2013-12-31: -23193000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Operating Cash Flow: -23193000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23193000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#567716 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	USD 505,000 Exact value Exact value: 505000 USD 2013-01-01 – 2013-12-31: 505000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Capital Expenditure: 505000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 505000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1082035 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.	−USD 23.7 million Calculation and evidence -23193000 − 505000 USD Exact free cash flow: -23698000 USD 2013-01-01 – 2013-12-31: -23193000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 505000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CADENCE PHARMACEUTICALS INC · 2013-12-31 CADENCE PHARMACEUTICALS INC (edgar:1333248) Free cash flow: -23698000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T15:47:16Z Snapshot: b70131751554a18a21798eaae4035ba85fdfe1d16eb9db3f044f0213b5010249 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333248?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23193000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#567716 Filing: 000119312514077365 Input fundies:CapitalExpenditure: 505000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333248/000119312514077365/cadx-20131231.xml#1082035 Filing: 000119312514077365 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 1,172 latest values · 1,172 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001333248, 1333248, CADX, edgar:1333248

Also known as CADENCE PHARMACEUTICALS INC

CADENCE PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation